Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TOFACITINIB Cause Multiple fractures? 188 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 188 reports of Multiple fractures have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.

188
Reports of Multiple fractures with TOFACITINIB
0.1%
of all TOFACITINIB reports
1
Deaths
138
Hospitalizations

How Dangerous Is Multiple fractures From TOFACITINIB?

Of the 188 reports, 1 (0.5%) resulted in death, 138 (73.4%) required hospitalization, and 2 (1.1%) were considered life-threatening.

Is Multiple fractures Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 188 reports have been filed with the FAERS database.

What Other Side Effects Does TOFACITINIB Cause?

Drug ineffective (30,382) Pain (21,659) Condition aggravated (16,925) Arthralgia (15,640) Fatigue (13,551) Rheumatoid arthritis (12,277) Off label use (11,736) Headache (11,061) Joint swelling (10,686) Malaise (9,040)

What Other Drugs Cause Multiple fractures?

EMTRICITABINE\TENOFOVIR DISOPROXIL (8,088) TENOFOVIR DISOPROXIL (6,793) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (4,102) COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (1,942) EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL (1,489) DENOSUMAB (415) NEXIUM (346) ADALIMUMAB (305) ETANERCEPT (251) ABATACEPT (217)

Which TOFACITINIB Alternatives Have Lower Multiple fractures Risk?

TOFACITINIB vs TOFERSEN TOFACITINIB vs TOLNAFTATE TOFACITINIB vs TOLODODEKIN ALFA TOFACITINIB vs TOLTERODINE TOFACITINIB vs TOLVAPTAN

Related Pages

TOFACITINIB Full Profile All Multiple fractures Reports All Drugs Causing Multiple fractures TOFACITINIB Demographics